| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72162-2072-1 | 72162-2072 | HUMAN PRESCRIPTION DRUG | PROPYLTHIOURACIL | PROPYLTHIOURACIL | TABLET | ORAL | 20230815 | N/A | ANDA | ANDA080154 | Bryant Ranch Prepack | PROPYLTHIOURACIL | 50 mg/1 | 100 TABLET in 1 BOTTLE (72162-2072-1) |
| 72162-2072-2 | 72162-2072 | HUMAN PRESCRIPTION DRUG | PROPYLTHIOURACIL | PROPYLTHIOURACIL | TABLET | ORAL | 20230815 | N/A | ANDA | ANDA080154 | Bryant Ranch Prepack | PROPYLTHIOURACIL | 50 mg/1 | 180 TABLET in 1 BOTTLE (72162-2072-2) |
| 70752-171-10 | 70752-171 | HUMAN PRESCRIPTION DRUG | PROPYLTHIOURACIL | PROPYLTHIOURACIL | TABLET | ORAL | 20210318 | N/A | ANDA | ANDA080154 | QUAGEN PHARMACEUTICALS LLC | PROPYLTHIOURACIL | 50 mg/1 | 100 TABLET in 1 BOTTLE (70752-171-10) |
| 70752-171-11 | 70752-171 | HUMAN PRESCRIPTION DRUG | PROPYLTHIOURACIL | PROPYLTHIOURACIL | TABLET | ORAL | 20210318 | N/A | ANDA | ANDA080154 | QUAGEN PHARMACEUTICALS LLC | PROPYLTHIOURACIL | 50 mg/1 | 1000 TABLET in 1 BOTTLE (70752-171-11) |